Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 272 entries
Sorted by: Best Match Show Resources per page
Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum].

International journal of nanomedicine

[No authors listed]
PMID: 26345514
Int J Nanomedicine. 2015 Aug 27;10:5421. doi: 10.2147/IJN.S87133. eCollection 2015.

No abstract available.

Cite
Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]. Int J Nanomedicine. 2015;10:5421doi: 10.2147/IJN.S87133.
(2015). Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]. International journal of nanomedicine, 105421. https://doi.org/10.2147/IJN.S87133
"Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]." International journal of nanomedicine vol. 10 (2015): 5421. doi: https://doi.org/10.2147/IJN.S87133
Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]. Int J Nanomedicine. 2015 Aug 27;10:5421. doi: 10.2147/IJN.S87133. eCollection 2015. PMID: 26345514; PMCID: PMC4554400.
Copy Download .nbib Format: NLM
Essential components of a successful doctoral program in nanomedicine.

International journal of nanomedicine

van de Ven AL, Shann MH, Sridhar S.
PMID: 25565801
Int J Nanomedicine. 2014 Dec 19;10:23-30. doi: 10.2147/IJN.S69144. eCollection 2015.

The Nanomedicine program at Northeastern University provides a unique interdisciplinary graduate education that combines experiential research, didactic learning, networking, and outreach. Students are taught how to apply nanoscience and nanotechnology to problems in medicine, translate basic research to the...

Cite
van de Ven AL, Shann MH, Sridhar S. Essential components of a successful doctoral program in nanomedicine. Int J Nanomedicine. 2014;10:23-30doi: 10.2147/IJN.S69144.
van de Ven, A. L., Shann, M. H., & Sridhar, S. (2015). Essential components of a successful doctoral program in nanomedicine. International journal of nanomedicine, 1023-30. https://doi.org/10.2147/IJN.S69144
van de Ven, Anne L, et al. "Essential components of a successful doctoral program in nanomedicine." International journal of nanomedicine vol. 10 (2015): 23-30. doi: https://doi.org/10.2147/IJN.S69144
van de Ven AL, Shann MH, Sridhar S. Essential components of a successful doctoral program in nanomedicine. Int J Nanomedicine. 2014 Dec 19;10:23-30. doi: 10.2147/IJN.S69144. eCollection 2015. PMID: 25565801; PMCID: PMC4278779.
Copy Download .nbib Format: NLM
Undetactable levels of genotoxicity of SiO2 nanoparticles in in vitro and in vivo tests [Erratum].

International journal of nanomedicine

Kwon JY, Kim HL, Lee JY.
PMID: 26229465
Int J Nanomedicine. 2015 Jul 21;10:4621. doi: 10.2147/IJN.S79827. eCollection 2015.

No abstract available.

Cite
Kwon JY, Kim HL, Lee JY. Undetactable levels of genotoxicity of SiO2 nanoparticles in in vitro and in vivo tests [Erratum]. Int J Nanomedicine. 2015;10:4621doi: 10.2147/IJN.S79827.
Kwon, J. Y., Kim, H. L., & Lee, J. Y. (2015). Undetactable levels of genotoxicity of SiO2 nanoparticles in in vitro and in vivo tests [Erratum]. International journal of nanomedicine, 104621. https://doi.org/10.2147/IJN.S79827
Kwon, J Y, et al. "Undetactable levels of genotoxicity of SiO2 nanoparticles in in vitro and in vivo tests [Erratum]." International journal of nanomedicine vol. 10 (2015): 4621. doi: https://doi.org/10.2147/IJN.S79827
Kwon JY, Kim HL, Lee JY. Undetactable levels of genotoxicity of SiO2 nanoparticles in in vitro and in vivo tests [Erratum]. Int J Nanomedicine. 2015 Jul 21;10:4621. doi: 10.2147/IJN.S79827. eCollection 2015. PMID: 26229465; PMCID: PMC4514354.
Copy Download .nbib Format: NLM
Nanomedicine: promises and challenges for the future of public health.

International journal of nanomedicine

Pautler M, Brenner S.
PMID: 21042425
Int J Nanomedicine. 2010 Oct 05;5:803-9. doi: 10.2147/IJN.S13816.

As the scope of nanotechnology applications in medicine evolves, it is important to simultaneously recognize and advance contributions germane to public health. A wide range of innovations in nanomedicine stand to impact nearly every medical specialty and unveil novel...

Cite
Pautler M, Brenner S. Nanomedicine: promises and challenges for the future of public health. Int J Nanomedicine. 2010;5:803-9doi: 10.2147/IJN.S13816.
Pautler, M., & Brenner, S. (2010). Nanomedicine: promises and challenges for the future of public health. International journal of nanomedicine, 5803-9. https://doi.org/10.2147/IJN.S13816
Pautler, Michelle, and Brenner, Sara. "Nanomedicine: promises and challenges for the future of public health." International journal of nanomedicine vol. 5 (2010): 803-9. doi: https://doi.org/10.2147/IJN.S13816
Pautler M, Brenner S. Nanomedicine: promises and challenges for the future of public health. Int J Nanomedicine. 2010 Oct 05;5:803-9. doi: 10.2147/IJN.S13816. PMID: 21042425; PMCID: PMC2962275.
Copy Download .nbib Format: NLM
Retraction. Particokinetics: computational analysis of the superparamagnetic iron oxide nanoparticles deposition process.

International journal of nanomedicine

[No authors listed]
PMID: 23049257
Int J Nanomedicine. 2012;7:5107. doi: 10.2147/IJN.S37825. Epub 2012 Sep 21.

No abstract available.

Cite
Retraction. Particokinetics: computational analysis of the superparamagnetic iron oxide nanoparticles deposition process. Int J Nanomedicine. 2012;7:5107doi: 10.2147/IJN.S37825.
(2012). Retraction. Particokinetics: computational analysis of the superparamagnetic iron oxide nanoparticles deposition process. International journal of nanomedicine, 75107. https://doi.org/10.2147/IJN.S37825
"Retraction. Particokinetics: computational analysis of the superparamagnetic iron oxide nanoparticles deposition process." International journal of nanomedicine vol. 7 (2012): 5107. doi: https://doi.org/10.2147/IJN.S37825
Retraction. Particokinetics: computational analysis of the superparamagnetic iron oxide nanoparticles deposition process. Int J Nanomedicine. 2012;7:5107. doi: 10.2147/IJN.S37825. Epub 2012 Sep 21. PMID: 23049257; PMCID: PMC3459686.
Copy Download .nbib Format: NLM
Erratum: Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum].

International journal of nanomedicine

[No authors listed]
PMID: 28761345
Int J Nanomedicine. 2017 Jul 17;12:5119. doi: 10.2147/IJN.S145516. eCollection 2017.

[This corrects the article on p. 3735 in vol. 12, PMID: 28553111.].

Cite
Erratum: Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]. Int J Nanomedicine. 2017;12:5119doi: 10.2147/IJN.S145516.
(2017). Erratum: Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]. International journal of nanomedicine, 125119. https://doi.org/10.2147/IJN.S145516
"Erratum: Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]." International journal of nanomedicine vol. 12 (2017): 5119. doi: https://doi.org/10.2147/IJN.S145516
Erratum: Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]. Int J Nanomedicine. 2017 Jul 17;12:5119. doi: 10.2147/IJN.S145516. eCollection 2017. PMID: 28761345; PMCID: PMC5522671.
Copy Download .nbib Format: NLM
Erratum: Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum].

International journal of nanomedicine

[No authors listed]
PMID: 30122923
Int J Nanomedicine. 2018 Aug 07;13:4507. doi: 10.2147/IJN.S178282. eCollection 2018.

[This corrects the article on p. 585 in vol. 13, PMID: 29430178.].

Cite
Erratum: Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum]. Int J Nanomedicine. 2018;13:4507doi: 10.2147/IJN.S178282.
(2018). Erratum: Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum]. International journal of nanomedicine, 134507. https://doi.org/10.2147/IJN.S178282
"Erratum: Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum]." International journal of nanomedicine vol. 13 (2018): 4507. doi: https://doi.org/10.2147/IJN.S178282
Erratum: Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum]. Int J Nanomedicine. 2018 Aug 07;13:4507. doi: 10.2147/IJN.S178282. eCollection 2018. PMID: 30122923; PMCID: PMC6086565.
Copy Download .nbib Format: NLM
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines--in vitro studies [Corrigendum].

International journal of nanomedicine

[No authors listed]
PMID: 26396510
Int J Nanomedicine. 2015 Sep 14;10:5769. doi: 10.2147/IJN.S83181. eCollection 2015.

No abstract available.

Cite
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines--in vitro studies [Corrigendum]. Int J Nanomedicine. 2015;10:5769doi: 10.2147/IJN.S83181.
(2015). Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines--in vitro studies [Corrigendum]. International journal of nanomedicine, 105769. https://doi.org/10.2147/IJN.S83181
"Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines--in vitro studies [Corrigendum]." International journal of nanomedicine vol. 10 (2015): 5769. doi: https://doi.org/10.2147/IJN.S83181
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines--in vitro studies [Corrigendum]. Int J Nanomedicine. 2015 Sep 14;10:5769. doi: 10.2147/IJN.S83181. eCollection 2015. PMID: 26396510; PMCID: PMC4577265.
Copy Download .nbib Format: NLM
Carbon nanotube-based substrates promote cardiogenesis in brown adipose-derived stem cells via β1-integrin-dependent TGF-β1 signaling pathway.

International journal of nanomedicine

Sun H, Mou Y, Li Y, Li X, Chen Z, Duval K, Huang Z, Dai R, Tang L, Tian F.
PMID: 27660434
Int J Nanomedicine. 2016 Sep 06;11:4381-4395. doi: 10.2147/IJN.S114357. eCollection 2016.

Stem cell-based therapy remains one of the promising approaches for cardiac repair and regeneration. However, its applications are restricted by the limited efficacy of cardiac differentiation. To address this issue, we examined whether carbon nanotubes (CNTs) would provide an...

Cite
Sun H, Mou Y, Li Y, et al. Carbon nanotube-based substrates promote cardiogenesis in brown adipose-derived stem cells via β1-integrin-dependent TGF-β1 signaling pathway. Int J Nanomedicine. 2016;11:4381-4395doi: 10.2147/IJN.S114357.
Sun, H., Mou, Y., Li, Y., Li, X., Chen, Z., Duval, K., Huang, Z., Dai, R., Tang, L., & Tian, F. (2016). Carbon nanotube-based substrates promote cardiogenesis in brown adipose-derived stem cells via β1-integrin-dependent TGF-β1 signaling pathway. International journal of nanomedicine, 114381-4395. https://doi.org/10.2147/IJN.S114357
Sun, Hongyu, et al. "Carbon nanotube-based substrates promote cardiogenesis in brown adipose-derived stem cells via β1-integrin-dependent TGF-β1 signaling pathway." International journal of nanomedicine vol. 11 (2016): 4381-4395. doi: https://doi.org/10.2147/IJN.S114357
Sun H, Mou Y, Li Y, Li X, Chen Z, Duval K, Huang Z, Dai R, Tang L, Tian F. Carbon nanotube-based substrates promote cardiogenesis in brown adipose-derived stem cells via β1-integrin-dependent TGF-β1 signaling pathway. Int J Nanomedicine. 2016 Sep 06;11:4381-4395. doi: 10.2147/IJN.S114357. eCollection 2016. PMID: 27660434; PMCID: PMC5019277.
Copy Download .nbib Format: NLM
Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation.

International journal of nanomedicine

Hong SS, Choi JY, Kim JO, Lee MK, Kim SH, Lim SJ.
PMID: 27660440
Int J Nanomedicine. 2016 Sep 06;11:4465-4477. doi: 10.2147/IJN.S113723. eCollection 2016.

Studies have highlighted the challenge of developing injectable liposomes as a paclitaxel (PTX) carrier, a challenge attributable to the limitations in liposomal stability caused by PTX loading. Poor stability of PTX-loaded liposomes is caused by PTX-triggered aggregation or fusion...

Cite
Hong SS, Choi JY, Kim JO, et al. Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation. Int J Nanomedicine. 2016;11:4465-4477doi: 10.2147/IJN.S113723.
Hong, S. S., Choi, J. Y., Kim, J. O., Lee, M. K., Kim, S. H., & Lim, S. J. (2016). Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation. International journal of nanomedicine, 114465-4477. https://doi.org/10.2147/IJN.S113723
Hong, Soon-Seok, et al. "Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation." International journal of nanomedicine vol. 11 (2016): 4465-4477. doi: https://doi.org/10.2147/IJN.S113723
Hong SS, Choi JY, Kim JO, Lee MK, Kim SH, Lim SJ. Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation. Int J Nanomedicine. 2016 Sep 06;11:4465-4477. doi: 10.2147/IJN.S113723. eCollection 2016. PMID: 27660440; PMCID: PMC5019274.
Copy Download .nbib Format: NLM
Erratum: Antibacterial properties and toxicity from metallic nanomaterials [Corrigendum].

International journal of nanomedicine

[No authors listed]
PMID: 30410334
Int J Nanomedicine. 2018 Oct 16;13:6497. doi: 10.2147/IJN.S183907. eCollection 2018.

[This corrects the article on p. 3941 in vol. 12, PMID: 28579779.].

Cite
Erratum: Antibacterial properties and toxicity from metallic nanomaterials [Corrigendum]. Int J Nanomedicine. 2018;13:6497doi: 10.2147/IJN.S183907.
(2018). Erratum: Antibacterial properties and toxicity from metallic nanomaterials [Corrigendum]. International journal of nanomedicine, 136497. https://doi.org/10.2147/IJN.S183907
"Erratum: Antibacterial properties and toxicity from metallic nanomaterials [Corrigendum]." International journal of nanomedicine vol. 13 (2018): 6497. doi: https://doi.org/10.2147/IJN.S183907
Erratum: Antibacterial properties and toxicity from metallic nanomaterials [Corrigendum]. Int J Nanomedicine. 2018 Oct 16;13:6497. doi: 10.2147/IJN.S183907. eCollection 2018. PMID: 30410334; PMCID: PMC6199210.
Copy Download .nbib Format: NLM
Erratum: Gentamicin coating of nanotubular anodized titanium implant reduces implant-related osteomyelitis and enhances bone biocompatibility in rabbits [Corrigendum].

International journal of nanomedicine

[No authors listed]
PMID: 28894362
Int J Nanomedicine. 2017 Aug 26;12:6219. doi: 10.2147/IJN.S148516. eCollection 2017.

[This corrects the article on p. 5461 in vol. 12, PMID: 28814863.].

Cite
Erratum: Gentamicin coating of nanotubular anodized titanium implant reduces implant-related osteomyelitis and enhances bone biocompatibility in rabbits [Corrigendum]. Int J Nanomedicine. 2017;12:6219doi: 10.2147/IJN.S148516.
(2017). Erratum: Gentamicin coating of nanotubular anodized titanium implant reduces implant-related osteomyelitis and enhances bone biocompatibility in rabbits [Corrigendum]. International journal of nanomedicine, 126219. https://doi.org/10.2147/IJN.S148516
"Erratum: Gentamicin coating of nanotubular anodized titanium implant reduces implant-related osteomyelitis and enhances bone biocompatibility in rabbits [Corrigendum]." International journal of nanomedicine vol. 12 (2017): 6219. doi: https://doi.org/10.2147/IJN.S148516
Erratum: Gentamicin coating of nanotubular anodized titanium implant reduces implant-related osteomyelitis and enhances bone biocompatibility in rabbits [Corrigendum]. Int J Nanomedicine. 2017 Aug 26;12:6219. doi: 10.2147/IJN.S148516. eCollection 2017. PMID: 28894362; PMCID: PMC5584917.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 272 entries